Literature DB >> 18546152

Proteomic profiling of CHO cells with enhanced rhBMP-2 productivity following co-expression of PACEsol.

Paula Meleady1, Michael Henry, Patrick Gammell, Padraig Doolan, Martin Sinacore, Mark Melville, Linda Francullo, Mark Leonard, Timothy Charlebois, Martin Clynes.   

Abstract

Chinese hamster ovary (CHO) cells are widely used for the production of recombinant protein biopharmaceuticals. The purpose of this study was to investigate differences in the proteome of CHO DUKX cells expressing recombinant human bone morphogenetic protein-2 (rhBMP-2) (G5 cells) compared to cells also expressing soluble exogenous paired basic amino acid cleaving enzyme soluble paired basic amino acid cleaving enzyme (PACEsol) (3C9 cells), which has been previously found to improve the post-translational processing of the mature rhBMP-2 dimer. PACEsol co-expression was also associated with a significant increase (almost four-fold) in cellular productivity of rhBMP-2 protein. Differential proteomic expression profiling using 2-D DIGE and MALDI-TOF MS was performed to compare 3C9 and G5 cells, and revealed a list of 60 proteins that showed differential expression (up/downregulated), with a variety of different cellular functions. A substantial number of these altered proteins were found to have chaperone activity, involved with protein folding, assembly and secretion, as well as a number of proteins involved in protein translation. These results support the use of proteomic profiling as a valuable tool towards understanding the biology of bioprocess cultures.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18546152     DOI: 10.1002/pmic.200700854

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  13 in total

1.  The changes of serum proteome and tissular pathology in mouse induced by botulinum toxin E injection.

Authors:  J F Wang; X Y Mao; C Zhao
Journal:  Mol Biol Rep       Date:  2014-01-24       Impact factor: 2.316

2.  Comprehensive tracking of host cell proteins during monoclonal antibody purifications using mass spectrometry.

Authors:  Qingchun Zhang; Andrew M Goetze; Huanchun Cui; Jenna Wylie; Steve Trimble; Art Hewig; Gregory C Flynn
Journal:  MAbs       Date:  2014-02-11       Impact factor: 5.857

Review 3.  Growth factors in orthopaedic surgery: demineralized bone matrix versus recombinant bone morphogenetic proteins.

Authors:  Maurice Hinsenkamp; Jean-Francois Collard
Journal:  Int Orthop       Date:  2014-10-22       Impact factor: 3.075

4.  The factor VII-activating protease (FSAP) enhances the activity of bone morphogenetic protein-2 (BMP-2).

Authors:  Elfie Kathrin Roedel; Elisabeth Schwarz; Sandip Madhav Kanse
Journal:  J Biol Chem       Date:  2013-01-22       Impact factor: 5.157

5.  Optimized procedure for expression and renaturation of recombinant human bone morphogenetic protein-2 at high protein concentrations.

Authors:  Hongbin Zhang; Jie Wu; Yu Zhang; Na Fu; Jie Wang; Shujin Zhao
Journal:  Mol Biol Rep       Date:  2009-10-13       Impact factor: 2.316

6.  Compartmentalized Proteomic Profiling Outlines the Crucial Role of the Classical Secretory Pathway during Recombinant Protein Production in Chinese Hamster Ovary Cells.

Authors:  Saumel Pérez-Rodriguez; Tune Wulff; Bjørn G Voldborg; Claudia Altamirano; Mauricio A Trujillo-Roldán; Norma A Valdez-Cruz
Journal:  ACS Omega       Date:  2021-05-03

7.  A multi-omics analysis of recombinant protein production in Hek293 cells.

Authors:  Stefanie Dietmair; Mark P Hodson; Lake-Ee Quek; Nicholas E Timmins; Peter Gray; Lars K Nielsen
Journal:  PLoS One       Date:  2012-08-24       Impact factor: 3.240

8.  Sustained productivity in recombinant Chinese hamster ovary (CHO) cell lines: proteome analysis of the molecular basis for a process-related phenotype.

Authors:  Paula Meleady; Padraig Doolan; Michael Henry; Niall Barron; Joanne Keenan; Finbar O'Sullivan; Colin Clarke; Patrick Gammell; Mark W Melville; Mark Leonard; Martin Clynes
Journal:  BMC Biotechnol       Date:  2011-07-24       Impact factor: 2.563

9.  Recombinant human butyrylcholinesterase as a new-age bioscavenger drug: development of the expression system.

Authors:  D G Ilyushin; O M Haertley; T V Bobik; O G Shamborant; E A Surina; V D Knorre; P Masson; I V Smirnov; A G Gabibov; N A Ponomarenko
Journal:  Acta Naturae       Date:  2013-01       Impact factor: 1.845

10.  Transcriptome study and identification of potential marker genes related to the stable expression of recombinant proteins in CHO clones.

Authors:  Uros Jamnikar; Petra Nikolic; Ales Belic; Marjanca Blas; Dominik Gaser; Andrej Francky; Holger Laux; Andrej Blejec; Spela Baebler; Kristina Gruden
Journal:  BMC Biotechnol       Date:  2015-10-23       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.